Eli Lilly and Co LLY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:44 AM EST
209.76quote price arrow up+2.85 (+1.37%)
Volume
946,672
52 week range
117.06 - 218.00

...

Loading . . .

KEY STATS

  • Open207.00
  • Day High210.24
  • Day Low206.32
  • Prev Close206.92
  • 52 Week High218.00
  • 52 Week High Date01/29/21
  • 52 Week Low117.06
  • 52 Week Low Date03/23/20
  • Market Cap201.045B
  • Shares Out958.43M
  • 10 Day Average Volume3.28M
  • Dividend3.40
  • Dividend Yield1.62%
  • Beta0.30
  • 1 Year % Change48.23

RATIOS/PROFITABILITY

  • EPS (TTM)6.79
  • P/E (TTM)30.90
  • Fwd P/E (NTM)25.12
  • EBITDA (MRQ)8.174B
  • ROE (MRQ)150.18%
  • Revenue (MRQ)24.54B
  • Gross Margin (MRQ)77.66%
  • Net Margin (MRQ)25.24%
  • Debt To Equity (MRQ)294.16%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date02/11/2021
  • Div Amount0.85
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its...
David Ricks
Chairman
Anat Ashkenazi
Chief Financial Officer
Address
Lilly Corporate Ctr
Drop Code 1094, Lilly Corporate Ctr
Indianapolis, IN
46285-0001
United States